Shorena Janelidze
161 – 170 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
- Contribution to journal › Article
- 2018
-
Mark
Amyloid blood biomarker detects Alzheimer's disease
- Contribution to journal › Article
-
Mark
Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
- Contribution to journal › Article
-
Mark
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
- Contribution to journal › Article
- 2017
-
Mark
Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
- Contribution to journal › Article
-
Mark
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
- Contribution to journal › Article
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
- Contribution to journal › Article
-
Mark
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
- Contribution to journal › Article
